US Stock Insider Trading | SpyGlass Pharma disclosed 14 insider transactions on February 11

2026-02-22 18:03:33

Abstract generation in progress

On February 11, 2026, SpyGlass Pharma (SGP) disclosed 14 insider trading transactions. Shareholder RA CAPITAL MANAGEMENT, L.P., holding more than 10% of shares, purchased 3.442 million shares on February 9, 2026.

【Recent Insider Transactions】

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 11, 2026	Shareholder with over 10%	BASKETT FOREST, Chang Carmen, Florence Anthony A. Jr., Mathers Edward T, New Enterprise Associates 17, L.P., SANDELL SCOTT D, Walker Paul Edward, Yang Rick	February 9, 2026	Buy	7.5 million	16.00	$120 million
February 11, 2026	Director	Khan Bilal Arshad, Pardo Geoffrey B	February 9, 2026	Buy	447,500	16.00	$7.16 million
February 11, 2026	Shareholder with over 10%	Behbahani Ali, RA CAPITAL MANAGEMENT, L.P.	February 9, 2026	Buy	4.6275 million	16.00	$74.04 million
February 10, 2026	Shareholder with over 10%	Vensana Capital I GP, LLC	February 9, 2026	Buy	165,000	16.00	$2.64 million
February 10, 2026	Director	Nielsen Kirk G.	February 9, 2026	Buy	165,000	16.00	$2.64 million

【Company Information】

SpyGlass Pharma, Inc. was incorporated under Delaware law on January 7, 2019. The company is a late-stage biopharmaceutical company that is initiating Phase 3 clinical trials of its lead product, a drug delivery system that is IOL-mounted, controlled-release, designed to deliver bimatoprost to treat glaucoma. Its mission is to significantly improve the lives of patients with chronic eye diseases by developing long-lasting drug delivery solutions that give patients and surgeons confidence in long-term disease management and vision preservation.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes